Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Repligen Cp (RGEN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,489,723
  • Shares Outstanding, K 43,810
  • Annual Sales, $ 141,240 K
  • Annual Income, $ 28,350 K
  • 36-Month Beta 0.72
  • Price/Sales 17.63
  • Price/Cash Flow 65.71
  • Price/Book 4.16

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/18
See More
  • Average Estimate 0.18
  • Number of Estimates 5
  • High Estimate 0.19
  • Low Estimate 0.16
  • Prior Year 0.15
  • Growth Rate Est. (year over year) +20.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
50.81 +8.71%
on 08/22/18
58.99 -6.36%
on 09/14/18
+3.99 (+7.79%)
since 08/21/18
3-Month
45.00 +22.76%
on 08/02/18
58.99 -6.36%
on 09/14/18
+9.64 (+21.14%)
since 06/21/18
52-Week
29.56 +86.87%
on 02/09/18
58.99 -6.36%
on 09/14/18
+11.09 (+25.12%)
since 09/21/17

Most Recent Stories

More News
Global Hollow Fiber Filtration Market to 2023 - Key Players Include Asahi Kasei, Repligen, GE Healthcare and Danaher

The "Hollow Fiber Filtration Market by Technique (Microfiltration, Ultrafiltration), Material (Polymer, Ceramic), Application (Harvest & Clarification, Concentration, Perfusion), End User (Pharmaceutical...

RGEN : 55.24 (-2.80%)
Shares of RGEN Up 55.6% Since Uptrend Call on Shares

SmarTrend identified an Uptrend for Repligen Corp (NASDAQ:RGEN) on February 22nd, 2018 at $34.93. In approximately 6 months, Repligen Corp has returned 55.65% as of today's recent price of $54.36.

RGEN : 55.24 (-2.80%)
Recent Analysis Shows STMicroelectronics N.V, Jagged Peak Energy, Inovalon, AC Immune SA, Repligen, and RealNetworks Market Influences -- Renewed Outlook, Key Drivers of Growth

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of STMicroelectronics N.V. (NYSE:STM),...

ACIU : 8.60 (+1.90%)
JAG : 13.91 (+0.94%)
RNWK : 2.82 (-3.09%)
RGEN : 55.24 (-2.80%)
STM : 18.82 (-1.26%)
INOV : 10.65 (-4.48%)
Repligen Reaches Analyst Target Price

In recent trading, shares of Repligen Corp. have crossed above the average analyst 12-month target price of $51.14, changing hands for $51.25/share.

RGEN : 55.24 (-2.80%)
Uptrend Call Working As Repligen Corp Stock Rises 40.1% (RGEN)

SmarTrend identified an Uptrend for Repligen Corp (NASDAQ:RGEN) on February 22nd, 2018 at $34.93. In approximately 6 months, Repligen Corp has returned 40.13% as of today's recent price of $48.94.

RGEN : 55.24 (-2.80%)
Repligen (RGEN) Misses Q2 Earnings Estimates

Repligen (RGEN) delivered earnings and revenue surprises of -11.11% and 3.62%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?

RGEN : 55.24 (-2.80%)
Repligen: 2Q Earnings Snapshot

WALTHAM, Mass. (AP) _ Repligen Corp. (RGEN) on Thursday reported second-quarter earnings of $2.7 million.

RGEN : 55.24 (-2.80%)
Repligen Reports Second Quarter 2018 Financial Results

-- Record quarterly revenue of $47.7 million represents 47% year-over-year growth

RGEN : 55.24 (-2.80%)
Repligen Corporation to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / August 2, 2018 / Repligen Corporation (NASDAQ: ) will be discussing their earnings results in their Q2 Earnings Call to be held on August 2, 2018 at 8:30 AM Eastern Time.

RGEN : 55.24 (-2.80%)
Today's Research Reports on Trending Tickers: Halozyme Therapeutics and Repligen

NEW YORK, NY / ACCESSWIRE / August 1, 2018 / Wall Street snapped its losing streak on Tuesday as investors digested better-than-expected quarterly earnings and after the Trump administration appeared...

RGEN : 55.24 (-2.80%)
HALO : 17.53 (+1.56%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More Share

Trade RGEN with:

Business Summary

Repligen Corporation is a life sciences company focused on the development, production and commercialization of high-value consumable products used in the process of manufacturing biological drugs. Their bioprocessing products are sold to major life sciences and biopharmaceutical companies worldwide....

See More

Key Turning Points

2nd Resistance Point 58.37
1st Resistance Point 56.80
Last Price 55.24
1st Support Level 54.40
2nd Support Level 53.57

See More

52-Week High 58.99
Last Price 55.24
Fibonacci 61.8% 47.75
Fibonacci 50% 44.28
Fibonacci 38.2% 40.80
52-Week Low 29.56

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar